Thromb Haemost 1989; 61(03): 343-347
DOI: 10.1055/s-0038-1646592
Original Article
Schattauer GmbH Stuttgart

The Use of DNA Amplification for Genetic Counselling Related Diagnosis in Haemophilia B

T C Tsang
1   The Paediatric Research Unit, Division of Medical and Molecular Genetics, United Medical and Dental Schools of Guy’s and St Thomas’s Hospitals, Guy’s Hospital Tower, London, United Kingdom
,
D R Bentley
1   The Paediatric Research Unit, Division of Medical and Molecular Genetics, United Medical and Dental Schools of Guy’s and St Thomas’s Hospitals, Guy’s Hospital Tower, London, United Kingdom
,
I M Nilsson
2   The Department of Coagulation, University Hospital, Malmö, Sweden
,
F Giannelli
1   The Paediatric Research Unit, Division of Medical and Molecular Genetics, United Medical and Dental Schools of Guy’s and St Thomas’s Hospitals, Guy’s Hospital Tower, London, United Kingdom
› Author Affiliations
Further Information

Publication History

Received 04 November 1988

Accepted 16 January 1989

Publication Date:
24 July 2018 (online)

Summary

A single base pair variation in the coding sequence of coagulation factor IX produces a protein polymorphism detectable with monoclonal antibodies and a restriction fragment length polymorphism (RFLP). This allows carrier and prenatal diagnoses in 48% of Caucasian families segregating for haemophilia B. However, this RFLP cannot be detected by standard Southern blotting, while the antibody assay may grve equivocal results in some females and can only allow prenatal diagnoses on second trimester fetal blood samples. We show that, using the polymerase chain reaction, the polymorphic DNA segment can be amplified and directly tested for the presence of the alternative sequences by a non-radioactive procedure that has the advantage of speed (1–2 days), partial automation and applicability to first trimester diagnoses. We also show that the method gives results on a single drop of dried blood.

 
  • References

  • 1 Giannelli F. The contribution of gene specific probes to the genetic counselling of families segregating for haemophilia B. In: Factor VIII/ Von Willebrand Factor – Biological and Clinical Advances. Ciavarella NL, Ruggieri ZM, Zimmerman TS. (eds) Wichtig Editore; Milan: 1986: 159-174
  • 2 Giannelli F. The identification of haemophilia B mutations. In: Protides of the Biological Fluids 35. Peeters H. (ed) Pergamon Press; Oxford: 1987: 29-32
  • 3 Brownlee GG. Haemophilia B: a review of patient defects, diagnosis with gene probes and prospects for gene therapy. In: Recent Advances in Haematology 5. Hoffman AV. (ed) Churchill Livingstone; Edinburgh: (in press)
  • 4 Hay CW, Robertson KA, Yong S-L, Thompson GH, Growe GH, MacGillivray RT A. Use of a Bam HI polymorphism in the factor IX gene for the determination of haemophilia B carrier status. Blood 1986; 67: 1508-1511
  • 5 Winship PR, Brownlee GG. Diagnosis of haemophilia B carriers using intragenic oligonucleotide probes. Lancet 1986; 2: 218-219
  • 6 McGraw RA, Davis LM, Noyes CM, Graham JB, Roberts HR, Stafford DW. Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX. Proc Natl Acad Sci USA 1985; 82: 2847-2851
  • 7 Wallmark A, Ljung R, Nilsson IM, Holmberg L, Hedner U, Lindvall M, Sjogren H-O. Polymorphism of normal factor IX detected by mouse monoclonal antibodies. Proc Natl Acad Sci USA 1985; 82: 3839-3843
  • 8 Smith KJ. Monoclonal antibodies to coagulation factor IX define high-frequency polymorphism by immunoassays. Am J Hum Genet 1985; 37: 668-679
  • 9 Graham JB, Lubahn DB, Lord ST, Kirshtein J, Nilsson IM, Wallmark A, Ljung R, Frazier LD, Ware JL, Lin S-W, Stafford DW, Bosco J. The Malmö polymorphism of coagulation factor IX, an immunologic polymorphism due to dimorphism of residue 148 that is in linkage disequilibrium with two other F. IX polymorphisms. Am J Hum Genet 1988; 42: 573-580
  • 10 Smith KJ, Thompson AR, McMullen BA, Frazier D, Lin S-W, Stafford D, Kisiel W, Thibodeau SN, Chen S-H, Smith LF. Carrier testing in haemophilia B with an immunoassay that distinguishes a prevalent factor IX dimorphism. Blood 1987; 70: 1006-1013
  • 11 Lyon MF. Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 1962; 14: 135-148
  • 12 Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Amheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anaemia. Science 1985; 230: 1350-1354
  • 13 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491
  • 14 Kogan SC, Doherty M, Gitschier J. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences: application to hemophilia A. N Engl J Med 1987; 317: 985-990
  • 15 Higuchi R, von Beroldingen CH, Sensabaugh GF, Erlich HA. DNA typing from single hairs. Nature 1988; 332: 543-546
  • 16 Wallmark A, Ljung R, Nilsson I-M. Determination of factor IX allotypes for carrier identification in haemophilia B. Br J Haematol 1987; 67: 427-432
  • 17 Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press; Cold Spring Harbor:
  • 18 Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (anti- haemophilic factor IX). Biochemistry 1985; 24: 3736-3750